Cryptdin 21 inhibitors are part of a class of antimicrobial peptides, specifically cryptdins, which are primarily expressed in the intestinal Paneth cells. These peptides, including cryptdin 21, play an essential role in the innate immune response, acting as a defense mechanism against a broad spectrum of microorganisms. Characterized by their cationic and amphipathic properties, cryptdin 21 and its inhibitors are adept at interacting with and disrupting the membranes of various pathogens, such as bacteria, fungi, and viruses. The structure of cryptdin 21 includes specific amino acid sequences that allow it to adopt a helical conformation, enabling it to penetrate microbial membranes effectively. This membrane-disrupting capability is fundamental to its role in modulating the gut microbiome and maintaining intestinal homeostasis.
Inhibitors of cryptdin 21 can function through several mechanisms that impede its antimicrobial activity. These inhibitors may bind to the peptide itself, preventing it from adopting the appropriate conformation needed for effective membrane insertion. They could also interfere with the electrostatic interactions between cryptdin 21 and microbial membranes, thereby reducing the peptide's ability to disrupt membrane integrity. Furthermore, some inhibitors might alter the membrane composition or structure of the target pathogens, making them less susceptible to cryptdin 21's action. The exploration of cryptdin 21 inhibitors provides valuable insights into the intricate dynamics of host defense systems, particularly in the gut environment. Understanding these interactions enhances the knowledge of how antimicrobial peptides can be regulated and modulated, contributing to the overall balance of the gut microbiome and the host's immune response.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Daptomycin, a lipopeptide antibiotic, directly inhibits cryptdin 21 by disrupting bacterial cell membrane integrity. This inhibition contributes to the modulation of the antimicrobial humoral immune response and innate immune response in mucosa. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil, an antimetabolite, indirectly inhibits cryptdin 21 by interfering with nucleic acid synthesis. This influences the antimicrobial humoral immune response mediated by antimicrobial peptides and the innate immune response in mucosa. | ||||||
Pentoxifylline | 6493-05-6 | sc-203184 | 1 g | $20.00 | 3 | |
Pentoxifylline, a phosphodiesterase inhibitor, indirectly inhibits cryptdin 21 by modulating inflammatory signaling pathways. This impacts the antimicrobial humoral immune response mediated by antimicrobial peptides and the innate immune response in mucosa. | ||||||
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
Auranofin, a gold complex, indirectly inhibits cryptdin 21 by modulating redox signaling pathways. This influences the antimicrobial humoral immune response mediated by antimicrobial peptides and the innate immune response in mucosa. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin, a platinum-containing chemotherapeutic agent, indirectly inhibits cryptdin 21 by inducing DNA damage. This affects the antimicrobial humoral immune response mediated by antimicrobial peptides and the innate immune response in mucosa. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide, an immunomodulatory agent, indirectly inhibits cryptdin 21 by modulating cytokine production. This influences the antimicrobial humoral immune response mediated by antimicrobial peptides and the innate immune response in mucosa. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
N-Acetyl-L-cysteine (NAC), an antioxidant, indirectly inhibits cryptdin 21 by scavenging reactive oxygen species. This influences the antimicrobial humoral immune response mediated by antimicrobial peptides and the innate immune response in mucosa. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $78.00 $142.00 | 23 | |
Itraconazole, an antifungal agent, directly inhibits cryptdin 21 by interfering with fungal cell membrane function. This contributes to the modulation of the antimicrobial humoral immune response and innate immune response in mucosa. | ||||||
Fluticasone propionate | 80474-14-2 | sc-218517 | 10 mg | $184.00 | ||
Fluticasone propionate, a glucocorticoid receptor agonist, indirectly inhibits cryptdin 21 by suppressing inflammatory pathways. This affects the antimicrobial humoral immune response mediated by antimicrobial peptides and the innate immune response in mucosa. | ||||||
Glycyrrhizic acid | 1405-86-3 | sc-279186 sc-279186A | 1 g 25 g | $57.00 $333.00 | 7 | |
Glycyrrhizic acid, a triterpene glycoside, indirectly inhibits cryptdin 21 by modulating inflammatory signaling. This influences the antimicrobial humoral immune response mediated by antimicrobial peptides and the innate immune response in mucosa. | ||||||